Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA-dependent protein kinase (DNA-PK) is a serine/threonine protein kinase complex that plays a central role in the repair of DNA double-strand breaks (DSBs) through the non-homologous end joining (NHEJ) pathway. It is also involved in V(D)J recombination, which is essential for immune system diversity. The complex consists of the catalytic subunit DNA-PKcs and the regulatory Ku heterodimer (Ku70 and Ku80). Activation requires binding to both the Ku heterodimer and exposed DNA ends at DSBs. DNA-PK is essential for repairing DSBs caused by ionizing radiation or other genotoxic stresses and is required for assembling antigen receptor genes in developing lymphocytes. It activates p53 following severe damage to trigger apoptosis if repair capacity is exceeded. Knockout or mutation leads to severe combined immunodeficiency (SCID). DNA-PK is also involved in mitosis regulation and possibly other cellular processes beyond canonical DSB repair pathways.
Inhibition of DNA-PK catalytic activity, preventing DNA repair and inducing apoptosis in cancer cells.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA-dependent Protein Kinase (DNA-PK).